Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries ProtoKinetix Announces Annual General Stockholder Meeting Will Be Held Virtually Only By: ProtoKinetix, Incorporated via Business Wire January 14, 2022 at 12:15 PM EST ProtoKinetix, Incorporated (www.protokinetix.com) (the "Company" or "ProtoKinetix") (OTCQB: PKTX), a clinical-stage biomedical company, today announced that it will hold its Annual General Meeting of the Stockholders of the Company (“AGM”) virtually with no option to attend the AGM in person due to ongoing COVID-19 concerns. As set forth in the Company’s definitive proxy materials as filed with the Securities and Exchange Commission on December 30, 2021, the AGM will be held on Friday, February 11, 2022 at 4:00 p.m. Eastern Standard Time, via webcast at: www.virtualshareholdermeeting.com/PKTX2022. If you have not received your proxy package, please contact the Company directly: Clarence E. Smith President and Chief Executive Officer Telephone: 740-434-5041 Email: csmith@protokinetix.com About ProtoKinetix, Incorporated Cautionary Note Regarding Forward-Looking Statements The information discussed in this press release includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements, other than statements of historical facts, included herein concerning, among other things, planned capital expenditures, future cash flows and borrowings, pursuit of potential acquisition opportunities, our financial position, business strategy and other plans and objectives for future operations, are forward looking statements. Although we believe that the expectations reflected in these forward-looking statements are reasonable, they do involve certain assumptions, risks and uncertainties and are not (and should not be considered to be) guarantees of future performance. Refer to our risk factors set forth in our reports filed on Edgar. ProtoKinetix disclaims any obligation to update any forward-looking statement made here. This press release does not constitute or form a part of any offer or solicitation to purchase or subscribe for securities in the United States. View source version on businesswire.com: https://www.businesswire.com/news/home/20220114005374/en/Contacts Clarence E. Smith President and Chief Executive Officer Telephone: 740-434-5041 Email: csmith@protokinetix.com Twitter: @ProtoKinetix Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
ProtoKinetix Announces Annual General Stockholder Meeting Will Be Held Virtually Only By: ProtoKinetix, Incorporated via Business Wire January 14, 2022 at 12:15 PM EST ProtoKinetix, Incorporated (www.protokinetix.com) (the "Company" or "ProtoKinetix") (OTCQB: PKTX), a clinical-stage biomedical company, today announced that it will hold its Annual General Meeting of the Stockholders of the Company (“AGM”) virtually with no option to attend the AGM in person due to ongoing COVID-19 concerns. As set forth in the Company’s definitive proxy materials as filed with the Securities and Exchange Commission on December 30, 2021, the AGM will be held on Friday, February 11, 2022 at 4:00 p.m. Eastern Standard Time, via webcast at: www.virtualshareholdermeeting.com/PKTX2022. If you have not received your proxy package, please contact the Company directly: Clarence E. Smith President and Chief Executive Officer Telephone: 740-434-5041 Email: csmith@protokinetix.com About ProtoKinetix, Incorporated Cautionary Note Regarding Forward-Looking Statements The information discussed in this press release includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements, other than statements of historical facts, included herein concerning, among other things, planned capital expenditures, future cash flows and borrowings, pursuit of potential acquisition opportunities, our financial position, business strategy and other plans and objectives for future operations, are forward looking statements. Although we believe that the expectations reflected in these forward-looking statements are reasonable, they do involve certain assumptions, risks and uncertainties and are not (and should not be considered to be) guarantees of future performance. Refer to our risk factors set forth in our reports filed on Edgar. ProtoKinetix disclaims any obligation to update any forward-looking statement made here. This press release does not constitute or form a part of any offer or solicitation to purchase or subscribe for securities in the United States. View source version on businesswire.com: https://www.businesswire.com/news/home/20220114005374/en/Contacts Clarence E. Smith President and Chief Executive Officer Telephone: 740-434-5041 Email: csmith@protokinetix.com Twitter: @ProtoKinetix
ProtoKinetix, Incorporated (www.protokinetix.com) (the "Company" or "ProtoKinetix") (OTCQB: PKTX), a clinical-stage biomedical company, today announced that it will hold its Annual General Meeting of the Stockholders of the Company (“AGM”) virtually with no option to attend the AGM in person due to ongoing COVID-19 concerns. As set forth in the Company’s definitive proxy materials as filed with the Securities and Exchange Commission on December 30, 2021, the AGM will be held on Friday, February 11, 2022 at 4:00 p.m. Eastern Standard Time, via webcast at: www.virtualshareholdermeeting.com/PKTX2022. If you have not received your proxy package, please contact the Company directly: Clarence E. Smith President and Chief Executive Officer Telephone: 740-434-5041 Email: csmith@protokinetix.com About ProtoKinetix, Incorporated Cautionary Note Regarding Forward-Looking Statements The information discussed in this press release includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements, other than statements of historical facts, included herein concerning, among other things, planned capital expenditures, future cash flows and borrowings, pursuit of potential acquisition opportunities, our financial position, business strategy and other plans and objectives for future operations, are forward looking statements. Although we believe that the expectations reflected in these forward-looking statements are reasonable, they do involve certain assumptions, risks and uncertainties and are not (and should not be considered to be) guarantees of future performance. Refer to our risk factors set forth in our reports filed on Edgar. ProtoKinetix disclaims any obligation to update any forward-looking statement made here. This press release does not constitute or form a part of any offer or solicitation to purchase or subscribe for securities in the United States. View source version on businesswire.com: https://www.businesswire.com/news/home/20220114005374/en/
Clarence E. Smith President and Chief Executive Officer Telephone: 740-434-5041 Email: csmith@protokinetix.com Twitter: @ProtoKinetix